ALKERMES | ALKS - PE Price to Earnings

Stock Price
27.98
Daily Change
0.22 0.79%
Monthly
-14.95%
Yearly
-18.59%
Q1 Forecast
26.93

ALKERMES reported 19.54 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
ALKERMES 19.54 4.64 Dec/2025
Amgen 25.31 15.82 Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 23.62 0.86 Dec/2025
Malin Corporation 11.81 0.72 Jun/2023
Merck 13.92 5.08 Dec/2025
Neurocrine Biosciences 835.47 802.2 Dec/2025
Otsuka Holdings 12.07 3.16 Dec/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pfizer 14.48 5.18 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025